Thursday, December 6, 2018

Time Session
1:30 pm – 3:00 pm Concurrent Workshop Session A 1
Motivational Interviewing: Revolutionize Your Clinical Practice

Presenters: Carla Marienfeld, MD, UCSD Psychiatry; Brian Hurley, MD, UCLA; Natassia Gaznick, MD, UCSD Psychiatry

Educational Objectives:

  1. Describe the meaning of the ‘righting reflex’ and the spirit of MI.
  2. Identify and utilize the four metaprocesses to structure an MI session.
  3. Practice reflections, identifying change talk, and core skills in MI.
  4. Demonstrate the core skills in MI in clinical practice.
1:30 pm – 3:00 pm Concurrent Workshop Session A 2
The Impact of Alcohol and Illicit Drugs on Sleep

Presenters: Bhanu Prakash Kolla, MD, MRC Psych, Mayo Clinic; Meghna Mansukhani, MD, Mayo Clinic; Subhajit Chakravorty, MD, Perelman School of Medicine

Educational Objectives:

  1. Discuss the impact of alcohol and other illicit substances on sleep. Learning objective.
  2. Recognize the role of sleep disruption in increasing the risk of relapse.
  3. Determine the mechanisms by which alcohol and other drugs can impact sleep disordered breathing.
  4. Evaluate and treat patients with co-morbid sleep and addiction disorders.
1:30 pm – 3:00 pm Concurrent Workshop Session A 3
Understanding and Translating Medical Literature: Practical Applications for Clinicians

Presenters: Edward Thomas Lewis, MD, Medical University of South Carolina; Kevin Gray, MD, Medical University of South Carolina; Allison Lin, MD, University of Michigan; Christopher Hammond, MD, Johns Hopkins University School of Medicine

Educational Objectives:

  1. Describe and interpret commonly utilized statistical methods commonly employed in clinical research study design.
  2. Distinguish clinically relevant medical literature and develop a framework for critically appraising research findings.
  3. Integrate clinical research findings into everyday practice by utilizing skills taught in the workshop including comprehension of common statistical methods, critical review of the literature, and understanding limitations of research study design.
1:30 pm – 3:00 pm Concurrent Workshop Session A 4
Alcohol and Opioid Use Disorders: Special Considerations in Older AdultsPresenters: Stephanie Hrisko, MD, Palmetto Health USC; Rebecca Payne, MD, Palmetto Health USC; Bruce Bassi, MD, Northwestern University; Ishani Dalal, DO, Positive Sobriety Institute

Educational Objectives:

  1. Describe the importance of screening for substance use disorders in older adult patients.
  2. Describe how alcohol and opioid use disorders may impact older adults differently than younger adults.
  3. Identify the most appropriate treatment options for older adult patients with alcohol and opioid use disorders accounting for age-related changes, medical comorbidities, and polypharmacy.
1:30 pm – 3:00 pm Concurrent Workshop Session A 5
Supporting Providers After a Patient Overdose Death

Presenter: Amy Yule, MD, Harvard Medical School, Massachusetts General Hospital; Nalan Ward, MD, Harvard Medical School, Massachusetts General Hospital; Frances Levin, MD, Columbia University

Educational Objectives:

  1. Review therapeutic and legal issues to consider when working with families after an overdose death.
  2. Describe ways to care for themselves and support co-workers after an overdose death.
  3. Summarize possible quality, safety, and regulatory review procedures to follow after an overdose death.
1:30 pm – 3:00 pm Concurrent Workshop Session A 6
Strategies for Interdisciplinary Collaboration in the Treatment of Substance Use Disorders

Presenters: John Mariani, MD, Columbia University Medical Center; Nicole Kosanke, PhD, Center for Motivation and Change; Carrie Wilkens, PhD, Center for Motivation and Change

Educational Objectives:

  1. Discuss the rationale and methods of effective communication with other providers and with patients regarding treatment provided by others on treatment team.
  2. Identify and be able to anticipate pitfalls in collaboration, how to avoid when possible, and how to repair when they occur.
  3. Examine methods of collaboration that are currently occurring in own practice and ways they can be improved.
3:15 pm – 4:45 pm Concurrent Workshop Session B 1
Cannabis Use and Misuse in the Era of Legalization

Presenters: Robert Milin, MD, Associate Professor, University of Ottawa, Department of Psychiatry; Kevin Gray, MD, Professor, Department of Psychiatry, MUSC

Educational Objectives:

  1. Summarize the evidence on the potential risks and consequences of cannabis use and misuse in adolescence through adulthood on mental health outcomes.
  2. Discuss the myths and gaps in knowledge of cannabis use.
  3. Distinguish between the potential medical use of cannabis and any indication for its use in psychiatric disorders.
  4. Illustrate the messaging and resources as Psychiatrists we may choice to convey to patients and the public on cannabis use/misuse in the era of legalization.
3:15 pm – 4:45 pm Concurrent Workshop Session B 2
Urine Drug Screening 101: A Practical Guide for Clinicians

Presenters: Rebecca Payne, MD, University of South Carolina/Palmetto Health Medical Group; Stephanie Hrisko, MD, University of South Carolina/Palmetto Health Medical Group; Ishani Dalal, DO, Positive Sobriety Institute

Educational Objectives:

  1. Identify advantages and limitations of urine drug screening.
  2. Discuss detection times for urine drug screens and pharmacokinetics of commonly used substances of abuse and alcohol.
  3. Apply the information on the interpretation of urine drug screens through case presentations.
3:15 pm – 4:45 pm Concurrent Workshop Session B 3
Review of New Designer Drugs

Presenters: Thomas Penders, MD, MS, East Carolina University;Cornel Stanciu, MD, MRO, Dartmouth-Hitchcock; Jonathan Lee, MD, East Carolina University; Farley Center; Petros Levounis, MD, MA, Rutgers

Educational Objectives:

  1. Indicate the various new and emergent psychoactive substances and their epidemiological data.
  2. Discuss toxidromes related to use of these and various laboratory screens.
  3. Acquire knowledge of the behavioral profile of these new agents and management options.
3:15 pm – 4:45 pm Concurrent Workshop Session B 4
Utilizing Family Systems Thinking in Substance Use Disorders Treatment

Presenters: Peter Steinglass, MD, Clinical Professor of Psychiatry, Weill-Cornell Medical College; Edward Paul, MD, Clinical Assistant Professor, NYU School of Medicine

Educational Objectives:

  1. Discuss the core concepts underlying Systemic-Motivational Therapy and Internal Family Systems therapy.
  2. Illustrate the clinical techniques an addiction psychiatrist would use in applying SMT and IFS approaches to clinical situations.
  3. Identify potential barriers (both individual and institutional) to the implementation of these models in attendees’ clinical settings, and suggest strategies for overcoming these barriers.
  4. Exemplify motivation to get additional training in family systems approaches to addiction treatment.
3:15 pm – 4:45 pm Concurrent Workshop Session B 5
Casey’s Law Cases: Using Civil Commitment for Substance Use Disorders

Presenters: Corina Freitas, MSc, MD, MBA, GWU Psychiatry; Abhishek Jain, MD, Columbia University; Ryan Wagoner, MD, University of South Florida

Educational Objectives:

  1. Summarize the variability of U.S. laws authorizing civil commitment for substance use disorders.
  2. Appraise the utility and impact of civil commitment for substance use disorders in diverse settings and special patient populations.
  3. Apply civil commitment for substance use disorder laws in practical, case-based scenarios.
3:15 pm – 4:45 pm Concurrent Workshop Session B 6
Female Professional Advancement and Work-Life Balance

Presenters: Dana Sarvey, MD, McLean Hospital/Harvard Medical School; Shelly F. Greenfield, MD, MPH, Professor of Psychiatry, Harvard Medical School; Kristine M. Trustey Endowed Chair in Psychiatry; Kathleen Brady, MD, PhD, Distinguished University Professor, VP for Research, Medical University South Carolina; Ellen Edens, MD, MPE, MA, Assistant Professor of Psychiatry, Yale School of Medicine; Inbal Gafni, MD, MSc FRCPC DipABAM, Lecturer, University of Toronto; Staff Psychiatrist, Women’s College Hospital, Toronto, Canada; Ayana Jordan, MD, PhD, Assistant Professor, Yale University School of Medicine, Addiction Psychiatrist, Connecticut Mental; Peggy Stephens, MD, MAT, CEO and Medical Director, Madison State Hospital;Clinical Assistant Professor, Indiana School of Medicine

Educational Objectives:

  1. Discuss several representative models of the diverse career trajectories available to women within addiction psychiatry.
  2. Determine the balance and interplay between professional advancement and expected developmental milestones within a female professional’s personal life.
  3. Provide an opportunity for female professionals within the audience to ask questions, gain support, and network with other female professionals.
5:00 pm – 6:30 pm Non-peer Reviewed Workshop
How to Start an Addiction Fellowship Program

Presenter: Chair: Ellen Edens, MD

Educational Objectives:

  1. Describe the major steps necessary for applying for an ACGME accredited fellowship program in addiction psychiatry.
  2. Discuss resources to aid in establishing an addiction psychiatry fellowship.
  3. Determine ways to overcome several potential challenges in establishing an addiction psychiatry fellowship.
5:00 pm – 6:30 pm Non-peer Reviewed Workshop
Trainee Workshop: Addiction Career Buffet: The Path to Addiction Fellowship and Beyond

Presenter: Chair: Jose Vito, MD

Educational Objectives:

  1. Discuss the primary pros/cons of doing an addiction psychiatry fellowship.
  2. Determine the role of AAAP and how it is relevant to trainees and early career addiction psychiatrists.
  3. Discuss fellowship recruitment and/or employment opportunities with healthcare organization.
5:00 pm – 6:30 pm Non-peer Reviewed Workshop
The ABPN MOC Part III Pilot Project

Presenter: Joan Anzia, MD, Psychiatry Director and Chair of the Psychiatry MOC Pilot Committee

Educational Objectives:

  1. Describe the ABPN MOC Part III Pilot Project.
  2. Determine the impact that this pilot project and its successes may have on an ABPN diplomate.
  3. Discuss the ABPN MOC process.
5:00 pm – 6:30 pm Non-peer Reviewed Workshop
AAAP Grant Projects for OUDs: Updates and Practical Lessons for Your Community

Presenter: Chair: Frances Levin, MD (PCSS & STR-TA Medical Director)

Educational Objectives:

  1. Describe AAAP’s SAMHSA-funded projects (PCSS, STR-TA and justice initiative).
  2. Utilize PCSS and STR websites to identify and make use of the available educational resources.
  3. Define barriers to overcome in implementation of MAT.
  4. Identify two areas of need within the justice system for addiction specialists.
  5. List at least two lessons learned from the PCSS and STR projects.
  6. Utilize free mentoring/coaching program that allows primary care providers direct access to clinical experts in addiction psychiatry and addiction medicine.
5:00 pm – 6:30 pm Non-peer Reviewed Workshop
Highlights of Changes to the Revised PCSS MAT Waiver Training Course

Presenters: Chair: Stephen Wyatt, DO, Medical Director, Addiction Medicine, Atrium Health; Sanchit Maruti, MD, Medical Director, University of Vermont Medical Center; John Renner, Jr. MD, Professor of Psychiatry, Boston University School of Medicine, and Associate Chief of Psychiatry for the VA Boston Healthcare System

Educational Objectives:

  1. Describe the key changes present in the current version of MAT Training.
  2. Describe points of clinical emphasis from the various.
  3. Discuss FAQ’s from the revised training course.

Friday, December 7, 2018

Time Session
1:30 pm – 3:00 pm Concurrent Workshop Session C 1
Perioperative Pain Management of Patients with Opioid Use Disorders

Presenters: Nalan Ward, MD, Harvard Medical School/ Massachusetts General Hospital; Gregory Acampora, MD, Harvard Medical School/Massachusetts General Hospital; Mladen Nisavic, MD, Harvard Medical School/Massachusetts General Hospital

Educational Objectives:

  1. Summarize the existing perioperative pain management strategies.
  2. Recognize the challenges and the barriers faced by patients and the inpatient teams during perioperative phase.
  3. Describe the essential components of optimal perioperative pain management approaches of patients with OUD.
1:30 pm – 3:00 pm Concurrent Workshop Session C 2
Bad Moms: The Woes of the Pregnant Addicted Woman

Presenters: Nidal Moukaddam, MD, PhD, Baylor College of Medicine; Kimberly Park, MD, Baylor College of Medicine; Katherine Chetta, MD, University of Texas Health Science Center – Houston; Hind Moussa, MD, Kettering Health Network, University of Cincinnati College of Medicine

Educational Objectives:

  1. Describe current barriers to treatment of substance use in pregnant women.
  2. Review obstetric complications of SUD in pregnancy for the woman.
  3. Review neonatal complications of substances in utero.
  4. Discuss the bias & countertransference towards women with substance use disorders during pregnancy.
1:30 pm – 3:00 pm Concurrent Workshop Session C 3
Using Telehealth to Bring Opioid Use Disorder MAT to Rural Communities

Presenters: David Moore, MD, PhD, Yale University; Ellen Edens, MD, Yale University; Allison Lin, MD, University of Michigan; Kendra Weaver, Psy.D, Veterans Health Administration

Educational Objectives:

  1. Summarize how the Federal Ryan Haight Act and local state laws affect tele-prescribing of MAT.
  2. Describe two telehealth modalities that can be used to bring MAT to rural areas.
  3. Assess barriers to implementing MAT in rural communities.
1:30 pm – 3:00 pm Concurrent Workshop Session C 4
Addiction, Violence and Criminal Recidivism

Elie Aoun, MD, Columbia University; Laurence Westreich, MD, New York University School of Medicine; Lama Bazzi, MD, Maimonides Medical Center; Debra Pinals, MD, University of Michigan

Educational Objectives:

  1. Describe the intricacies of the relationship between SUD, violence and justice involvement.
  2. Recognize the social circumstances that contribute and cement this relationship.
  3. Review evidence based interventions shown to reduce criminal recidivism in the substance using populations.
1:30 pm – 3:00 pm Concurrent Workshop Session C 5
Substance Use Disorders in Transitional Age Youth

Presenters: Justine Welsh, MD, Emory University School of Medicine; Jessica Zoltani, MD, Yale Child Study Center / Yale Health Mental Health and Counseling; Dana Sarvey, MD, Harvard Medical School/McLean Hospital; Holly Peek,MD, Harvard Medical School/McLean Hospital; Associate Medical Director of Klarman Eating Disorders Center

Educational Objectives:

  1. Recognize the importance of providing tailored treatment to transitional age youth.
  2. Identify evidence-based treatment interventions for co-occurring disorders and other special considerations.
  3. Review treatment strategies in case format.
1:30 pm – 3:00 pm Concurrent Workshop Session C 6
Addiction Medical Management With Patients Who Use Cannabis

Presenters: Iman Parhami, MD, MPH, LA County Department of Mental Health; Children’s Hospital Los Angeles; Marissa Andres-Kim, MD, LA County Department of Mental Health; Brian Hurley, MD, MBA, DFASAM, LA County Department of Mental Health, UCLA

Educational Objectives:

  1. Describe the association between cannabis use, other substance use disorder, and psychiatric symptoms and conditions.
  2. Demonstrate a plan to address cannabis use in patients who use cannabis and who are being treated for a substance use disorder and/or other psychiatric condition.
  3. Apply motivational interviewing techniques to engage patients regarding their cannabis use.
8:00 pm – 10:00 pm Film Workshop
Addiction in Film 16: “Moonlight”

Presenters: Petros Levounis, MD, MA, Rutgers NJMS; Robert Rymowicz, DO, Rutgers NJMS; James Sherer, MD, Rutgers NJMS; Pallavi Joshi, DO, MA, Northwell Health

Educational Objectives:

  1. Utilize popular films to enhance didactics and teach the fundamentals of Addiction Psychiatry.
  2. Identify three discrepancies between scientific and cinematographic reality.
  3. Discuss the portrayal of addiction in the media from a cultural perspective.

Saturday, December 8, 2019

Time Session
3:30pm – 5:00 pm Concurrent Workshop D 1
Development of an Opioid Use Disorder Cascade of Care

Presenters: Arthur Robin Williams, MD, MBE; Columbia University, New York State Psychiatric Institute; Adam Bisaga, MD, Columbia University, New York State Psychiatric Institute

Educational Objectives:

  1. Discuss evidence-based addiction education to health care trainees and health professionals to enhance patient care and promote recovery.
  2. Determine the key stages of the OUD Treatment Cascade.
  3. Identify four or more specific applications of the Cascade affecting clinical practice.
3:30pm – 5:00 pm Concurrent Workshop D 2
Engaging Young People with Substance Use Disorders and their Families

Presenters: Amy Yule, MD, Harvard Medical School, Massachusetts General Hospital; Brandon Bergman, PhD, Harvard Medical School, Massachusetts General Hospital; Kevin Gray, MD, Medical University of South Carolina; Timothy Wilens, MD, Harvard Medical School, Massachusetts General Hospital; James McKowen, PhD, Harvard Medical School, Massachusetts General Hospital

Educational Objectives:

  1. Identify ways in which social network sites can be used to assess and help treat youth with harmful drinking patterns.
  2. Discuss cannabis with young people and parents who do not view cannabis as harmful.
  3. Develop treatment plans that involve medication for young people with opioid use disorders.
  4. Describe the general principles of the Community Reinforcement and Family Training protocol.
3:30pm – 5:00 pm Concurrent Workshop D 3
How Can I Introduce Buprenorphine Into a Twelve-Step-Oriented Treatment Program?

Presenters: Marc Galanter, MD, NYU School of Medicine; Marvin Seppala, MD, Hazelden Betty Ford Foundation; Richard Reis, MD, University of Washington; Jeffrey Selzer, MD, New York State Committee for Physician Health

Educational Objectives:

  1. Describe the policies of Twelve Step fellowships on which medications can be acceptable.
  2. Identify clinical-administrative problems associated with integrating MAT into programs.
  3. Define guidelines for addressing these problems in participants’ work settings.
3:30pm – 5:00 pm Concurrent Workshop D 4
Drug Courts: National Perspectives and Local Practices

Presenters: Debra Pinals, MD, University of Michigan; Carolyn Hardin, MPA, Chief of Research and Training, National Association of Drug Court Professionals

Educational Objectives:

  1. Describe the history and development of drug courts.
  2. Describe current drug court practices understanding the 10 key components to help set the stage.
  3. Utilize case vignettes to approach a drug court team meeting and participate in it.
3:30pm – 5:00 pm Concurrent Workshop D 5
A Multifaceted Approach for Integration of Addiction Treatments into Primary Care

Presenters: Brian Hurley, MD, MBA, DFASAM, LA County Department of Mental Health, UCLA; Jaesu Han, MD, University of California, Irvine; Dongchan Park, MD, Bedford VA Hospital; Adina Bowe, MD, Apogee Physicians; Hector Colon-Rivera, MD, University of Pennsylvania/Univ of Pittsburgh

Educational Objectives:

  1. Recognize the substance use disorder treatment gap and describe the importance of delivering substance use disorder treatment in general medical settings.
  2. Compare and contrast the four core components of integrated substance use disorder treatment delivered in general medical settings.
  3. Develop a strategy to deliver pharmacologic, psychosocial, integration/coordination, and educational/outreach services for substance use disorder treatment in general medical settings.
  4. Apply evidence-based implementation science practices to the practice of psychiatry in integrated general medical settings.
3:30pm – 5:00 pm Concurrent Workshop D 6
Advances in Harm Reduction – Psychotherapy and Medication Approaches

Presenters: Mark Green, MD, The Psych Garden; Andrew Tatarsky, PhD, The New School; Center for Optimal Living, NYC

Educational Objectives:

  1. Describe how Integrated Harm Reduction Psychotherapy frames engagement, therapy and medication management.
  2. Apply mindfulness and experiential techniques to tolerate, identify and deepen emotions, resolving ambivalence.
  3. Demonstrate prescribing controlled substances in a Harm Reduction framework considering risk, stage of recovery and goals of the patient.